Anti-Mouse CD45.1 FITC

Also known as: SJL, Ly5.1

Clone: A20

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 11-0453

Cat. No. Size
11-0453-81 50 ug
11-0453-82 100 ug
11-0453-85 500 ug

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Mouse CD45.1 FITC.

Click on image to view more information.

More Views

  • Data for Anti-Mouse CD45.1 FITC.
Description

Description: The A20 monoclonal antibody reacts with the mouse CD45 molecule, the leukocyte common antigen (LCA) in CD45.1-expressing mouse strains. The strains that express CD45.1 include SJL/J, DA, STS/A and RIII. CD45.1 is expressed by all leukocytes in these strains.

Details
Host Mouse
Isotype IgG2a, kappa
Reactivity Mouse
Conjugate FITC
Laser Blue Laser
Emit 518 nm
Excite 488 nm
Reported Applications Flow Cytometric Analysis
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
19-0453 Anti-Mouse CD45.1 Cy5 633 nm 670 nm FC RUO
93-0453 Anti-Mouse CD45.1 eFluor® 605NC 350 - 590 nm 605 nm FC RUO
48-0453 Anti-Mouse CD45.1 eFluor® 450 405 nm 450 nm FC RUO
14-0453 Anti-Mouse CD45.1 Purified FC, IP RUO
35-0453 Anti-Mouse CD45.1 PE-Cy5.5 (To Be Discontinued; See Replacement Formats: PerCP-Cy5.5) 488 nm 690 nm FC RUO
47-0453 Anti-Mouse CD45.1 APC-eFluor® 780 633 nm 780 nm FC RUO
25-0453 Anti-Mouse CD45.1 PE-Cy7 488 nm 760 nm FC RUO
15-0453 Anti-Mouse CD45.1 PE-Cy5 488 nm 670 nm FC RUO
13-0453 Anti-Mouse CD45.1 Biotin FC RUO
17-0453 Anti-Mouse CD45.1 APC 633 nm 660 nm FC RUO
45-0453 Anti-Mouse CD45.1 PerCP-Cy5.5 (PE-Cy5.5 replacement) 488 nm 690 nm FC RUO
12-0453 Anti-Mouse CD45.1 PE 488 nm 575 nm FC RUO
References

References:
Shen, F-W. (1981). "Monoclonal antibodies to mouse lymphocyte differentiation alloantigens. In Monoclonal antibodies and T cell Hybridomas; Perspective and technical advances, eds. Hammerling, G.J., U. Hammerling, and J.F. Kearney": 25-31.